首页> 外文OA文献 >NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones
【2h】

NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones

机译:发育中的大鼠黑质致密性多巴胺能神经元中含有NR2B和NR2D的突触NMDA受体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

NMDA receptors are present at glutamatergic synapses throughout the brain, and are important for the development and plasticity of neural circuits. Their subunit composition is developmentally regulated. We have investigated the developmental profile of functional synaptic NMDA receptor subunits in dopaminergic neurones of the substantia nigra pars compacta (SNc). In SNc dopaminergic neurones from rats aged postnatal day (P)7, ifenprodil inhibited NMDA-EPSCs with an estimated IC50 of 0.36 μm and a maximum inhibition of 73.5 ± 2.7% (10 μm), consistent with a substantial population of NR1/NR2B-containing diheteromeric receptors. UBP141, a novel NR2D-preferring antagonist, inhibited NMDA-EPSCs with an estimated IC50 of 6.2 μm. During postnatal development, the maximum inhibitory effect of 10 μm ifenprodil significantly decreased. However, NMDA-EPSCs were not inhibited by Zn2+ (200 nm) or potentiated by the Zn2+ chelator TPEN (1 μm), and the effect of UBP141 did not increase during development, indicating that NR2B subunits are not replaced with diheteromeric NR2A or NR2D subunits. The time course of the decay of NMDA-EPSCs was not significantly changed in ifenprodil at any age tested. Together, these data suggest that diheteromeric NR1/NR2A or NR1/NR2D receptors do not account for the ifenprodil-resistant component of the NMDA-EPSC. We propose that NR1/NR2B/NR2D triheteromers form a significant fraction of synaptic NMDA receptors during postnatal development. This is the first report of data suggesting NR2D-containing triheteromeric NMDA receptors at a brain synapse.
机译:NMDA受体存在于整个大脑的谷氨酸能突触中,对于神经回路的发育和可塑性至关重要。它们的亚基组成受到发育调节。我们研究了黑质致密部(SNc)的多巴胺能神经元中功能性突触NMDA受体亚基的发育概况。在来自出生后一天(P)7岁的大鼠的SNc多巴胺能神经元中,艾芬地尔抑制了NMDA-EPSC,估计IC50为0.36μm,最大抑制率为73.5±2.7%(10μm),与大量NR1 / NR2B-含有二聚体受体。 UBP141是一种新型的NR2D首选拮抗剂,可抑制NMDA-EPSC,估计IC50为6.2μm。在产后发育期间,最大剂量10μm艾芬地尔的抑制作用明显降低。但是,NMDA-EPSC不受Zn2 +(200 nm)的抑制或未被Zn2 +螯合剂TPEN(1μm)增强,并且在发育过程中UBP141的作用没有增加,表明NR2B亚基没有被二聚体NR2A或NR2D亚基取代。 。在任何试验年龄的艾芬地尔中,NMDA-EPSCs衰变的时间过程都没有显着改变。在一起,这些数据表明,二元异构的NR1 / NR2A或NR1 / NR2D受体不能解释NMDA-EPSC的耐艾芬地尔的成分。我们提出,NR1 / NR2B / NR2D三异聚体在产后发育过程中形成了突触的NMDA受体的重要部分。这是数据首次暗示大脑突触中含有NR2D的三聚体NMDA受体的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号